OREANDA-NEWS. The documents required for the registration of a vaccine against coronavirus of a new type, developed by the Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of the Russian Federation, are under examination. The registration of the drug will be made based on the results of the study, the press service of the Ministry told reporters.

Earlier, the Minister of Health of the Russian Federation Mikhail Murashko said that clinical trials of the vaccine of the Gamaleya Center were completed. Another vaccine, developed by the state research center for virology and biotechnology Vektor of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing of Russia, is now at the stage of clinical trials.

The Ministry of Health plans to start mass vaccination of the population in October of the current year.